Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

7.08
+0.34005.04%
Post-market: 7.100.0200+0.28%17:40 EST
Volume:4.15M
Turnover:29.30M
Market Cap:649.78M
PE:4.34
High:7.29
Open:6.86
Low:6.80
Close:6.74
52wk High:19.70
52wk Low:6.18
Shares:91.78M
Float Shares:87.27M
Volume Ratio:0.92
T/O Rate:4.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.63
EPS(LYR):-0.5920
ROE:66.13%
ROA:-0.59%
PB:2.03
PE(LYR):-11.96

Loading ...

Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS

GlobeNewswire
·
Nov 25, 2025

ProMIS Neurosciences Announces Reverse Stock Split

GlobeNewswire
·
Nov 24, 2025

Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data

GlobeNewswire
·
Nov 24, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 24, 2025

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

GlobeNewswire
·
Nov 22, 2025

PagerDuty (PD): Assessing Valuation After Recent Share Slide and Shifting Growth Sentiment

Simply Wall St.
·
Nov 21, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GlobeNewswire
·
Nov 20, 2025

CMSC Initiates Coverage on 3SBIO (01530) with "Strong Buy" Rating, Citing PD-1/VEGF Bispecific Antibody as Catalyst for Revaluation

Stock News
·
Nov 20, 2025

Fosun Pharma's HLX10 (Serplulimab) Included in Breakthrough Therapy Program for Gastric Cancer Treatment

Stock News
·
Nov 20, 2025

Truist Lowers Price Target on PagerDuty to $20 From $23, Keeps Buy Rating

MT Newswires Live
·
Nov 19, 2025

Suzhou Zelgen Biopharmaceuticals (688266.SH) Receives Clinical Trial Approval for ZG006 Injection in Combination with PD-1/PD-L1 Inhibitors and Chemotherapy (Etoposide/Carboplatin)

Stock News
·
Nov 18, 2025

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights

GlobeNewswire
·
Nov 13, 2025

PagerDuty (PD) Gets a Buy from RBC Capital

TIPRANKS
·
Nov 13, 2025

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London

GlobeNewswire
·
Nov 13, 2025

Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 12, 2025

ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights

GlobeNewswire
·
Nov 12, 2025

Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update

Dow Jones
·
Nov 12, 2025

Press Release: PagerDuty to Report Third Quarter Fiscal Year 2026 Results on November 25, 2025

Dow Jones
·
Nov 12, 2025

Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire
·
Nov 11, 2025

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07, 2025